THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly for
in vitro testing and laboratory experimentation only.
All product information available on this website is for educational
purposes only. Bodily introduction of any kind into humans or animals
is strictly forbidden by law. This product should only be handled by
licensed, qualified professionals. This product is not a drug, food,
or cosmetic and may not be misbranded, misused or mislabeled as a drug,
food or cosmetic.
KLOW
KLOW is a four-peptide research blend consisting of BPC-157, TB-500, KPV, and GHK-Cu. It is supplied for laboratory investigation of coordinated signaling pathways involving nitric oxide modulation, cytoskeletal remodeling, NF-κB–associated transcriptional activity, and redox-related molecular markers. All applications are limited to non-clinical research use only.
Products will arrive in a lyophilized (powder) form to maximize stability and shelf life.
$189
FREE BAC Water for Peptide Orders over $250
Buy any peptide, get a vial of the same peptide FREE. Limited time only.
What It Is
KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 sequence), KPV, and GHK-Cu. The blend is supplied for experimental investigation of coordinated peptide signaling pathways in controlled laboratory systems.
What It’s Derived From
KLOW incorporates four independently characterized peptide sequences:
BPC-157 – derived from a partial sequence of a gastric protein known as body protection compound (BPC).
TB-500 – corresponds to the 43–amino–acid sequence motif of thymosin beta-4, an actin-binding peptide identified in eukaryotic cells.
KPV (Lys-Pro-Val) – derived from the C-terminal region of alpha-melanocyte–stimulating hormone (α-MSH).
GHK-Cu – formed from the naturally occurring tripeptide Gly-His-Lys complexed with copper(II), identified in human plasma and other biological fluids.
What Research Focuses On
Experimental models evaluate this peptide combination in studies examining nitric oxide–associated signaling, actin-cytoskeletal dynamics, NF-κB–related transcriptional pathways, extracellular matrix–associated molecular markers, and peptide–metal interaction mechanisms under defined preclinical conditions.
